ATE420889T1 - Betulinsäurederivate zur inhibierung des krebswachstums und ein verfahren zu ihrer herstellung - Google Patents

Betulinsäurederivate zur inhibierung des krebswachstums und ein verfahren zu ihrer herstellung

Info

Publication number
ATE420889T1
ATE420889T1 AT99964769T AT99964769T ATE420889T1 AT E420889 T1 ATE420889 T1 AT E420889T1 AT 99964769 T AT99964769 T AT 99964769T AT 99964769 T AT99964769 T AT 99964769T AT E420889 T1 ATE420889 T1 AT E420889T1
Authority
AT
Austria
Prior art keywords
derivatives
betulinic acid
acid derivatives
production
cancer growth
Prior art date
Application number
AT99964769T
Other languages
English (en)
Inventor
Sunder Ramadoss
Mannu Jaggi
Mohammad Siddiqui
Achla Khanna
Original Assignee
Dabur Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dabur Pharma Ltd filed Critical Dabur Pharma Ltd
Application granted granted Critical
Publication of ATE420889T1 publication Critical patent/ATE420889T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT99964769T 1998-11-18 1999-11-17 Betulinsäurederivate zur inhibierung des krebswachstums und ein verfahren zu ihrer herstellung ATE420889T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3458DE1998 1998-11-18

Publications (1)

Publication Number Publication Date
ATE420889T1 true ATE420889T1 (de) 2009-01-15

Family

ID=11092803

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99964769T ATE420889T1 (de) 1998-11-18 1999-11-17 Betulinsäurederivate zur inhibierung des krebswachstums und ein verfahren zu ihrer herstellung

Country Status (11)

Country Link
EP (1) EP1131337B1 (de)
JP (1) JP2002536382A (de)
KR (1) KR20010080507A (de)
CN (1) CN1326462A (de)
AT (1) ATE420889T1 (de)
AU (1) AU766599B2 (de)
BR (1) BR9915448A (de)
CA (1) CA2350786C (de)
DE (1) DE69940320D1 (de)
WO (1) WO2000046235A1 (de)
ZA (1) ZA200103616B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869535A (en) 1995-03-21 1999-02-09 The Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma
AU8494601A (en) 2000-08-18 2002-03-04 Univ Illinois Prodrugs of betulinic acid derivatives for the treatment of cancer and HIV
AU2001294953A1 (en) 2000-09-29 2002-04-08 Regents Of The University Of Minnesota Triterpenes having fungicidal activity against yeast
US6951847B2 (en) 2000-09-29 2005-10-04 Regents Of The University Of Minnesota Methods of treating fungal infections using lupeol
US6979470B2 (en) * 2001-07-17 2005-12-27 Metaproteomics, Llc Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
CN100432094C (zh) 2003-02-11 2008-11-12 诺瓦利克斯制药公司 抑制肿瘤生长的药物
EP1869063A2 (de) * 2005-03-29 2007-12-26 Regents Of The University Of Minnesota Verfahren zur herstellung biologisch aktiver 3-ester von betulinaldehyd und betulinsäure
GB0604535D0 (en) 2006-03-07 2006-04-12 Sndv Sprl Betulonic acid derivatives
CZ300722B6 (cs) * 2006-09-27 2009-07-22 Univerzita Karlova v Praze, Prírodovedecká fakulta Zpusob prípravy inkluzního komplexu pentacyklických a tetracyklických terpenoidu a farmaceutického prostredku obsahujícího tento inkluzní komplex, inkluzní komplex pentacyklického nebo tetracyklického terpenoidu a farmaceutický prostredek obsahující
US10047066B2 (en) * 2007-11-30 2018-08-14 Newlink Genetics Corporation IDO inhibitors
KR101027217B1 (ko) * 2009-03-11 2011-04-06 주식회사 바이오폴리메드 신규한 수용성 베툴린 유도체, 이의 제조방법 및 이를 포함하는 주름 개선용 화장료 조성물
US9067966B2 (en) 2009-07-14 2015-06-30 Hetero Research Foundation, Hetero Drugs Ltd. Lupeol-type triterpene derivatives as antivirals
US8802727B2 (en) 2009-07-14 2014-08-12 Hetero Research Foundation, Hetero Drugs Limited Pharmaceutically acceptable salts of betulinic acid derivatives
US9637516B2 (en) 2012-12-31 2017-05-02 Hetero Research Foundation Betulinic acid proline derivatives as HIV inhibitors
KR101531821B1 (ko) * 2013-11-27 2015-06-24 주식회사 휴메딕스 페길레이션된 베튤린 유도체를 포함하는 경구 투여용 항암제 조성물
US20170129916A1 (en) 2014-06-26 2017-05-11 Hetero Research Foundation Novel betulinic proline imidazole derivatives as hiv inhibitors
MA40886B1 (fr) 2015-02-09 2020-03-31 Hetero Research Foundation Nouveau triterpénone en c-3 avec des dérivés d'amide inverse en c-28 en tant qu'inhibiteurs du vih
US10370405B2 (en) 2015-03-16 2019-08-06 Hetero Labs Limited C-3 novel triterpenone with C-28 amide derivatives as HIV inhibitors
KR101909885B1 (ko) * 2018-05-25 2018-10-19 김예원 살리드로사이드 또는 베툴린을 이용한 뇌수막종 개선용 조성물
AU2019292599B2 (en) 2018-06-29 2022-03-03 Dfh Therapeutics Triterpene amine derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1415601A (en) * 1973-03-14 1975-11-26 Biorex Laboratories Ltd Dihydrobetulinic acid derivatives
US5869535A (en) * 1995-03-21 1999-02-09 The Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma
US5962527A (en) * 1995-03-21 1999-10-05 The Board Of Trustees Of The University Of Illinois Method and composition for treating cancers
EP0943620B1 (de) * 1998-03-18 2005-11-16 Dabur Pharma Ltd. Betulinsauer Derivate zur Hemmung von Krebswachstum

Also Published As

Publication number Publication date
AU766599B2 (en) 2003-10-16
WO2000046235A1 (en) 2000-08-10
ZA200103616B (en) 2002-02-19
EP1131337A1 (de) 2001-09-12
WO2000046235B1 (en) 2000-11-02
DE69940320D1 (de) 2009-03-05
EP1131337B1 (de) 2009-01-14
CA2350786C (en) 2008-08-12
JP2002536382A (ja) 2002-10-29
CA2350786A1 (en) 2000-08-10
CN1326462A (zh) 2001-12-12
KR20010080507A (ko) 2001-08-22
BR9915448A (pt) 2002-01-15
AU3073100A (en) 2000-08-25

Similar Documents

Publication Publication Date Title
ATE420889T1 (de) Betulinsäurederivate zur inhibierung des krebswachstums und ein verfahren zu ihrer herstellung
MX9707706A (es) Compuestos intermediarios novedosos y proceso para la manufactura de derivados de la camptotecina (cpt-11) y compuestos relacionados.
ATE306252T1 (de) Verfahren zur herstellung kristalliner partikel zur inhalation
TNSN05007A1 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof.
UA86760C2 (ru) Замещенные n-арилгетероциклы, способ их получения и их применение в качестве лекарственных средств
DE60316688D1 (de) Dehydrophenylahistine und analoge davon sowie ein verfahren zur herstellung von dehydrophenylahistinen und analogen davon
MY150538A (en) Process for the manufacture of dihydropteridinones
DE602004005323D1 (de) Azidfreies verfahren zur herstellung von 1,2-diaminoverbindungen
EE04777B1 (et) Kasvajavastased ühendid, neid sisaldavad farmatseutilised kompositsioonid ning nende kasutamine
DE60312029D1 (de) Verfahren zur herstellung c-7 substituierter 5-androstene
ATE252073T1 (de) Verfahren zur herstellung von esterquats
DE60008830D1 (de) Verfahren zur Herstellung von keramischen Zusammensetzungen
PL1751093T3 (pl) Podstawione pochodne kwasu cykloheksylooctowego
ATE457972T1 (de) Verfahren zur herstellung von 7-amino-syn-3,5- dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
TW200633977A (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
YU19302A (sh) 4-benzilaminohinolin konjugovan žučnom kiselinom i njegovi heteroanalozi, postupak za njihovu proizvodnju, lekovi koji sadrže ta jedinjenja i njihova primena
DE60224884D1 (de) Verfahren zur herstellung von 3, 3', 6, 6'-tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'-tetraalkylen-5, 5'-dihalo-2, 2' biphenolen
ATE236895T1 (de) Ringannelierte dihydropyrane, verfahren zur herstellung sowie deren verwendung
DE60106604D1 (de) Verwendung von aloe-emodin zur behandlung von neuroektodermalen tumoren
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
DE60112241D1 (de) Verfahren und zwischenverbindungen zur herstellung von imidazopyridinen
ATE242235T1 (de) Verfahren zur herstellung von (s-(r*,s*))-g(b)- ((1-(1-oxo-3-(4-piperidinyl)propyl)-3- piperidinyl)carbonyl) amino)-3- pyridinpropansäurederivate
GB9920959D0 (en) Novel process
GB0412865D0 (en) Chemical compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties